Exercise improves long-term benefits of GLP-1 drugs

Pairing GLP-1 therapy with regular exercise improves long-term health outcomes, reduces downstream costs and generates positive economic returns. The findings come from a white paper, titled From Weight Loss to Lasting Value: Structured Exercise and the Economics of GLP-1 Therapy. The paper analyses research that examined the long-term clinical and economic value of the use of structured exercise in tandem with GLP-1 treatments. Developed by FTI Consulting’s Center for Healthcare Economics and Policy, the white paper compares impacts of GLP-1 therapy as a standalone obesity treatment with GLP-1 therapy combined with exercise.